Thermo Fisher Scientific (Thermo Fisher Scientific) Change In Working Capital : $251 Mil (TTM As of Mar. 2024)

View and export this data going back to 1980. Start your Free Trial

What is Thermo Fisher Scientific Change In Working Capital?

Thermo Fisher Scientific's change in working capital for the quarter that ended in Mar. 2024 was $-787 Mil.

Thermo Fisher Scientific's change in working capital for the fiscal year that ended in Dec. 2023 was $-495 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Thermo Fisher Scientific Change In Working Capital Historical Data

The historical data trend for Thermo Fisher Scientific's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thermo Fisher Scientific Change In Working Capital Chart

Thermo Fisher Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

-615.00

-299.00

-1,514.00

-1,008.00

-495.00

Thermo Fisher Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Working Capital	Get a 7-Day Free Trial															-1,533.00	-718.00	-9.00	1,765.00	-787.00

Thermo Fisher Scientific Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $251 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Thermo Fisher Scientific Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Thermo Fisher Scientific (Thermo Fisher Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (NYSE:TMO) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

TMO:Peru TMO:Mexico TN8:Germany TN8:Germany TN8:Germany TMOS34:Brazil TMO:Argentina

Address

168 Third Avenue, Waltham, MA, USA, 02451

Website

https://www.thermofisher.com

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).

Executives

Marc N Casper	officer: Senior Vice President	C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Gianluca Pettiti	officer: Executive Vice President	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Stephen Williamson	officer: Sr. VP and CFO	81 WYMAN STREET, WALTHAM MA 02451
Jennifer M Johnson	director	C/O FRANKLIN RESOURCES, INC., ONE FRANKLIN PARKWAY, SAN MATEO CA 94403-1906
Michael A Boxer	officer: Sr. VP and Gen. Counsel	168 THIRD AVENUE, WALTHAM MA 02451
Lisa P. Britt	officer: Sr. VP and Chief HR Officer	168 THIRD AVENUE, WALTHAM MA 02451
Jim P Manzi	director	81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Debora L Spar	director	C/O GOLDMAN, SACHS & CO., 200 WEST STREET, NEW YORK NY 10282
Michel Lagarde	officer: Senior Vice President	450 LEXINGTON AVE., 31ST FLOOR, NEW YORK NY 10017
Ruby R Chandy	director	630 DUNDEE ROAD, SUITE 400, NORTHBROOK IL 60062
Mark P Stevenson	officer: Executive Vice President	850 LINCOLN CENTRE DRIVE, FOSTER CITY CA 94404
Joseph R. Holmes	officer: VP & Chief Accounting Officer	168 THIRD AVENUE, WALTHAM MA 02451
R. Alexandra Keith	director	ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Peter E Hornstra	officer: Chief Accounting Officer	81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Syed A. Jafry	officer: Sr. Vice President	345 E. MAIN STREET, WARSAW IN 46580